Mij
Senior Member (Voting Rights)
Introduction
The diagnostic criteria of postural orthostatic tachycardia syndrome (POTS) require heart rate (HR) increase of > 30 bpm in adults and > 40 bpm in patients aged 12–19 years within 10 min of assuming upright posture without orthostatic hypotension (OH) [1]. Autonomic symptoms and POTS are reported in association with coronavirus disease 2019 (COVID-19) [2, 3]; however, the association between POTS and COVID-19 vaccination is not well studied.
We report five patients who presented to SUNY Upstate Medical University autonomic clinic and dysautonomia center of excellence at UTHealth Houston to evaluate orthostatic intolerance that developed after receiving the COVID-19 vaccine. They were diagnosed with postural orthostatic tachycardia syndrome (POTS) after extensive evaluation. All patients underwent a head-up tilt table (HUTT) test [4]. Furthermore, patients 1 and 2 were examined for Q-Sweat, Valsalva, and heart rate response to deep breathing (HRDB); and patients 3, 4, and 5 underwent heart rate variability (HRV) spectral Fourier analysis [4].
https://link.springer.com/article/10.1007/s10286-022-00880-3
The diagnostic criteria of postural orthostatic tachycardia syndrome (POTS) require heart rate (HR) increase of > 30 bpm in adults and > 40 bpm in patients aged 12–19 years within 10 min of assuming upright posture without orthostatic hypotension (OH) [1]. Autonomic symptoms and POTS are reported in association with coronavirus disease 2019 (COVID-19) [2, 3]; however, the association between POTS and COVID-19 vaccination is not well studied.
We report five patients who presented to SUNY Upstate Medical University autonomic clinic and dysautonomia center of excellence at UTHealth Houston to evaluate orthostatic intolerance that developed after receiving the COVID-19 vaccine. They were diagnosed with postural orthostatic tachycardia syndrome (POTS) after extensive evaluation. All patients underwent a head-up tilt table (HUTT) test [4]. Furthermore, patients 1 and 2 were examined for Q-Sweat, Valsalva, and heart rate response to deep breathing (HRDB); and patients 3, 4, and 5 underwent heart rate variability (HRV) spectral Fourier analysis [4].
https://link.springer.com/article/10.1007/s10286-022-00880-3